SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001764013-20-000063
Filing Date
2020-11-12
Accepted
2020-11-12 08:30:38
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imvt-20200930.htm   iXBRL 10-Q 1545219
2 EX-31.1 exhibit311-q2.htm EX-31.1 10141
3 EX-31.2 exhibit312-q2.htm EX-31.2 10290
4 EX-32.1 exhibit321-q2.htm EX-32.1 5728
5 EX-32.2 exhibit322-q2.htm EX-32.2 5864
  Complete submission text file 0001764013-20-000063.txt   5875943

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20200930.xsd EX-101.SCH 36102
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imvt-20200930_cal.xml EX-101.CAL 66143
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imvt-20200930_def.xml EX-101.DEF 249653
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20200930_lab.xml EX-101.LAB 478566
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20200930_pre.xml EX-101.PRE 339274
11 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20200930_htm.xml XML 844084
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 201303626
SIC: 2836 Biological Products, (No Diagnostic Substances)